Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1905-1911

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v21,p1706)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Metzler, B.
Right arrow Articles by Wick, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Metzler, B.
Right arrow Articles by Wick, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
*PREDNISONE
Related Collections
Right arrow Animal models of human disease
Right arrow Pathophysiology
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1905-1911.)
© 1999 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Inhibition of Arteriosclerosis by T-Cell Depletion in Normocholesterolemic Rabbits Immunized With Heat Shock Protein 65

Bernhard Metzler; Manuel Mayr; Hermann Dietrich; Mahauir Singh; Evelyn Wiebe; Qingbo Xu; Georg Wick

From the Institute for Biomedical Aging Research, Austrian Academy of Sciences (B.M., M.M., Q.X., G.W.), and the Institute for General and Experimental Pathology, University of Innsbruck Medical School (B.M., M.M., H.D., G.W.), Innsbruck, Austria; GBF, Department of Genexpression (M.S.), Braunschweig, Germany; and Stressgen Biotechnologies Corp (E.W.), Victoria, BC, Canada. Dr Metzler is currently at the Division of Cardiology, Department of Internal Medicine, University Hospital of Innsbruck, Innsbruck, Austria.

Correspondence to Georg Wick, MD, Institute for Biomedical Aging Research, Austrian Academy of Sciences, Rennweg 10, A-6020 Innsbruck, Austria. E-mail IBA{at}oeaw.ac.at

Abstract—Previous studies in our laboratory have shown that arteriosclerotic changes can be induced in normocholesterolemic rabbits by immunization with mycobacterial heat shock protein (hsp) 65. To further investigate the immunologic mechanisms underlying such vascular lesions, 39 male New Zealand White rabbits were treated by triple immunization with fortified Freund's complete adjuvant containing 5 mg/mL Mycobacterium tuberculosis as a source of hsp65 and simultaneous immunosuppressive therapy twice per week with either anti-CD3 monoclonal antibody (1 mg/kg) and prednisolone (1 mg/kg) or prednisolone (1 mg/kg) alone. Sixteen weeks after the first immunization the animals were killed, and as expected, severe arteriosclerotic lesions in the intima of the aortic arch were found in 9 of 10 immunized rabbits. However, only 1 of 10 rabbits immunized and immunosuppressed with the combined anti-CD3 monoclonal antibody and prednisolone treatment showed a single moderate lesion in the aorta, whereas 5 of 9 rabbits immunized and immunosuppressed by prednisolone treatment alone showed lesions, albeit mild. In conclusion, the early inflammatory stages of arteriosclerotic lesions induced by immunization with hsp65 can be inhibited by immunosuppressive therapy with anti-CD3 monoclonal antibody.


Key Words: arteriosclerosis • immunosuppression • heat shock proteins • stress proteins • lymphocytes




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Benagiano, M. M. D'Elios, A. Amedei, A. Azzurri, R. van der Zee, A. Ciervo, G. Rombola, S. Romagnani, A. Cassone, and G. Del Prete
Human 60-kDa Heat Shock Protein Is a Target Autoantigen of T Cells Derived from Atherosclerotic Plaques
J. Immunol., May 15, 2005; 174(10): 6509 - 6517.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Mayr, S. Kiechl, M. A. Mendall, J. Willeit, G. Wick, and Q. Xu
Increased Risk of Atherosclerosis Is Confined to CagA-Positive Helicobacter pylori Strains: Prospective Results From the Bruneck Study
Stroke, March 1, 2003; 34(3): 610 - 615.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Maron, G. Sukhova, A.-M. Faria, E. Hoffmann, F. Mach, P. Libby, and H. L. Weiner
Mucosal Administration of Heat Shock Protein-65 Decreases Atherosclerosis and Inflammation in Aortic Arch of Low-Density Lipoprotein Receptor-Deficient Mice
Circulation, September 24, 2002; 106(13): 1708 - 1715.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
J C Ranford and B Henderson
Chaperonins in disease: mechanisms, models, and treatments
Mol. Pathol., August 1, 2002; 55(4): 209 - 213.
[Abstract] [Full Text] [PDF]